Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

A. Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, Katalin Susztak, Jonathan A. Coleman, Paul Russo, Andrew G. Winer, Roy Mano, Alexander I. Sankin, Robert J. Motzer, Martin H. Voss, Kenneth Offit, Mark Purdue, Mark Pomerantz, Matthew Freedman, Toni K. Choueiri, James J. Hsieh, Robert J. Klein

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences